Ihe mkpuchi ahụ 50mL maka mweghachi ụda ara nke buttock nke onye nrụpụta Label 

Kedu ihe bụ Filler ọkpọiso ma ọ dị mma?

Otu esi agbanwe site na Saxenda gaa Wegovy: oge, ime ihe na ihe ị ga-atụ anya ya

Ịgbanwe site na Saxenda (liraglutide, kwa ụbọchị) gaa Wegovy (semaglutide, kwa izu) bụ ihe a na-ahụkarị maka ndị ọrịa na-achọ nnukwu ibu ibu ma ọ bụ obere injections. Dabere na akara akwụkwọ gọọmentị US na ntuziaka ebipụtara, ntuziaka a na-akọwa ihe kpatara ndị ọrịa ji gbanwee, tụle usoro usoro onunu ogwu, wee kọwapụta usoro mgbanwe site na nzọụkwụ: enweghị ịsacha ọ bụla achọrọ, Wegovy nwere ike ịmalite ụbọchị mgbe usoro Saxenda ikpeazụ gasịrị, usoro mmalite bụ 0.25 mg (0.5 mg na-ewere na-ewepụ aha maka ụfọdụ ndị ọrịa kwụsiri ike na 3 mg), yana mmụba na-apụta kwa izu 4. Ọ na-ekpuchikwa nsonaazụ GI a na-atụ anya ya, nsonaazụ nnwale STEP 8, mmejọ ndị a na-ahụkarị yana ihe omume GLP-1 pụtara maka ụlọọgwụ mara mma na ndị nkesa.

Tranexamic Acid Mesotherapy maka Melasma: Protocol, Rịzọlt na Nchekwa

Tranexamic acid (TXA) mesotherapy abụrụla nhọrọ a na-aga maka ụlọọgwụ na-agwọ ọrịa melasma isi ike. Ntuziaka a na-akọwa otú TXA si akwụsị mgbaàmà plasmin nke na-eme ka mmepụta pigmenti, ihe ọmụmụ ụlọ ọgwụ bipụtara na-egosi (Lee 2006; Budamakuntla 2013), ka esi agba ọsọ usoro TXA intradermal, nke na-egbuke egbuke na-arụ ọrụ ya na nke ọma, isi nchekwa nchekwa, na ndepụta na-akpali akpali maka ndị na-ekesa na ụlọ ọgwụ na-achọ TX.